
COMPOUND PROPERTY CALCULATION & REMOVAL OF UNDESIRABLES
FILTER
FILTER is a very fast molecular filtering and selection application. It uses a combination of physical property calculations and functional group knowledge to remove undesirable compounds before they enter experimental or virtual screening.
Undesirable properties may include: toxic functionalities, a high likelihood of binding covalently with the target protein, interfering with the experimental assay, and/or a low probability of oral bioavailability.
Eliminating unwanted molecules before the use of modeling applications will, in turn, substantially increase the positive predictive value of these tools, and significantly reduce their processing time.
For more detailed information on FILTER, please click below:
Documentation
Removing undesirable compounds early makes the downstream processes significantly more efficient; a simple concept that is too often ignored.
Features
- Uses predefined filter files - text files that can be easily customized
- Filters based upon calculated properties such as: MW, XlogP [1], XlogS, PSA [2], hydrogen bond donor and acceptor count, rotatable bonds, ring size and number, etc.
- Removes or retains molecules based upon pre-defined or user-defined substructures
- Assigns graph-based protonation state for consistency and speed
- Offers ADME filters such as Lipinski [3], Egan [4], Veber [5] and Martin [6]
- Removes compounds with impossible bonding and inappropriate elements
- Generates tab-separated files suitable for import into spreadsheets
- Processes 400 mol/sec
References
- A New Atom-Additive Method for Calculating Partition Coefficients Wang, R., Ying, F., and Lai, L., J. Chem. Inf. Comput. Sci., 1997, 37, 615.
- Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties Ertl, P., Rohde, B., and Selzer, P., J. Med. Chem., 2000, 43, 3714.
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Lipinski, C., et al., Adv. Drug Deliv. Rev., 1997, 23, 3.
- Prediction of drug absorption using multivariate statistics Egan, W.J., Merz, K.M., Baldwin, J.J., J. Med. Chem., 2000, 43, 3867.
- Molecular Properties That Influence the Oral Bioavailability of Drug Candidates Veber, D.F., Johnson, S.R., Cheng, H.Y., Smith, B.R., Ward, K.W., Kipple, K.D., J. Med. Chem., 2002, 45, 2615.
- A bioavailability score Martin, Y.C., J. Med. Chem., 2005, 48, 3164.
miniCUP Cambridge 2025
miniCUP Basel 2025
Cadence Announces New Life Sciences Leadership
Expanding Orion’s Capabilities with AI
miniWebinar: Faster, Larger, Smarter: Filling the Funnel for Ultra-Large Scale Virtual Screening
miniCUP Basel 2025
Cadence Announces New Life Sciences Leadership
Expanding Orion’s Capabilities with AI
miniWebinar: Faster, Larger, Smarter: Filling the Funnel for Ultra-Large Scale Virtual Screening
Resources
Glimpse the Future through News, Events, Webinars and more
Event
miniCUP Cambridge 2025
miniCUP Cambridge 2025 will be held on May 6th, 2025 Registration is now open! miniCUP Cambridge is a single-day in-person gathering that will provide the opportunity to hear presentations from OpenEye and industry speakers, as well as learn about the latest scientific innovations and recent updates to the Orion® molecular design platform and our applications and toolkits. Plus stay for robust discussion at a cocktail reception following the event.
Read now
Event
miniCUP Basel 2025
miniCUP Basel 2025 will be held on May 8th, 2025 Registration is now open!
Read now

